RACHEL KEISER: Open Payments
NPI 1720621121 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$68 in 4 payments from 4 companies in 2025. Trend: 2023 $160 · 2024 $210 · 2025 $68
Food & beverage: $68
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Kerecis Limited | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Organon LLC | 1 | $13 |
Products named: CAPLYTA, Kerecis SurgiClose, Ozempic, NEXPLANON.
Industry payments across NE — which companies pay providers there.
